Stockreport

Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel's Opportunity in Relapsed or Refractory Multiple Myeloma [Yahoo! Finance]

Arcellx, Inc.  (ACLX) 
PDF SANTA MONICA, Calif., December 06, 2025 BUSINESS WIRE )--Kite, a Gilead Company (Nasdaq: GILD), and its partner Arcellx, today announced new positive data from its pivot [Read more]